Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

  • Topics
  • Results
  • Acknowledgement
2024.01.23
The PI Training Program_Kickoff Meeting was held for presentations and lively discussions.
2024.01.17
The 11th Steering Committee meeting was held and progress was shared with all members.
2023.12.22
The Support and Screening Committee for Startup Creation in FY2023 was held, and five new assignments were selected.
2023.11.15
Moonshot webinar "Recommendations for Light Sheet Microscopy" was held and attended by 54 people.
2023.10.27
JST 1st interim evaluation meeting was held.
2023.10.23
Pamphlet for Kento Imaging Support Center has been created.
PDF Download (Japanese only) >>
2023.10.11-13
Continuing from last year, we exhibited at Biojapan in collaboration with the Place for Co-Creation, National Circulation Center, Osaka Prefectural Government, and the Institute of Biomedical Innovation-Ken-Ei Kenkyuken.We exchanged information with visitors, focusing on the introduction of the newly launched "Organization for the Promotion of Health Metropolis Co-Creation" as well as the initiatives of the National Center for Medical Innovation.
  • Biojapan
  • Biojapan
  • Biojapan
2023.10.05
The second PI Training Program Review Committee meeting was held, and four new members were hired.
2023.09.04

A site visit to support the promotion of startup creation/growth under the Co-Creation Opportunity Formation Support Program (COI-NEXT) was held, where advice was given by members of the Startup Support Promotion Committee and a lively exchange of opinions took place.
Number of participants: 37 (on-site: 17, online: 20)

site visit

2022.10.25
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.
2022.08.17
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Association of liver enzymes and alcohol intake with risk of developing diabetes mellitus among urban area residents.
2022.07.25
Research and Development Project 6 Leader Yoshihiro Kokubo, Specially Appointed Director, has published on the Health Checkup Department WEB site.
Evidence from Japan of 10 items of lifelong health support to be used in the new health guidance of the Heart Failure Severe Prevention Project
2022.03.04
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Stair climbing and incident atrial fibrillation: a prospective cohort study
2022.01.26
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Mild Hypertensive Retinopathy and Risk of Cardiovascular Disease: The Suita Study
2021.12.08
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Developing a Stroke Risk Prediction Model Using Cardiovascular Risk Factors: The Suita Study --Stroke Risk in Urban Population. Cerebrovascular Diseases. 2021.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

List of TOPICS >

  • Northern Osaka Health and Biomedical Innovation Town KENTO
  • National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
  • National University Corporation Tokushima University
  • Eisai Co., Ltd.
  • KAN Research Institute, Inc.
  • Towa Pharmaceutical Co., Ltd.
  • Sysmex Corporation
  • Nipro Corporation
  • JSR Corporation
  • CYBERDYNE, Inc.
  • crossEffect, Inc.
  • CMIC HOLDINGS Co., Ltd.
  • Osaka Chamber of Commerce and Industry
  • Osaka Prefectural Government
  • Suita City
  • Settsu City
  • Mediford Corporation
  • Mizuho Bank, Ltd.
  • Kobe University
  • AIR WATER INC.
  • Kowa Company, Ltd.
  • JSPA(Japan Selfcare Promotion Association)
  • The SC approved MUFG Bank
  • Hankyu Hanshin Holdings Co., Ltd.
  • JCR Pharma Co., Ltd.
  • NEXGEN Co., Ltd.
  • Kyoto University
  • Osaka University
  • Shiga University of Medical Science
  • Kobe Pharmaceutical University
  • Osaka Metropolitan University
  • The Research Foundation for Microbial Diseases of Osaka University
  • Wellier Corporation
  • General Incorporated Association KENTO Co-Creation Promotion Organization (KCOP)